The stock market has been buzzing with activity lately. Stocks are rising, deals are happening, and companies are making important announcements, keeping the market in the spotlight. With so much going on, it can be hard to know what really matters. Don’t worry, we’ve got you covered. Here are the stocks to watch for today’s trading session.
Market Recap
Indian stock markets ended on a positive note on March 17. The Sensex jumped by 1,131.30 points, or 1.53%, to close at 75,301.26, while the Nifty gained 325.55 points, or 1.45%, to end at 22,834.30.
Stocks to Watch on March 19, 2025
Bajaj Auto
The board of Bajaj Auto has reappointed Rajiv Bajaj as MD and CEO for another five years, starting from April 1, 2025. Additionally, the company has approved an infusion of Rs 1,500 crore into Bajaj Auto Credit Ltd to strengthen its financial services arm.
LIC
State-owned Life Insurance Corporation of India (LIC) has officially confirmed its plans to expand into the health insurance sector. In a regulatory filing, LIC stated that it is in advanced talks to acquire a significant stake in a standalone health insurance company.
NTPC
Power giant NTPC is gearing up to raise Rs 4,000 crore by issuing Non-Convertible Debentures (NCDs) on March 20. These NCDs, with a 15-year tenure, will offer an annual coupon rate of 7.26%. The funds raised will be used for capital expenditure, loan refinancing, and general corporate needs.
Larsen & Toubro
Infrastructure major Larsen & Toubro (L&T) has scheduled a board meeting for March 21, 2025, to discuss a potential fundraising through a debt issue. The company confirmed that its board will consider the proposal to raise funds via debt instruments.
GR Infraprojects
GR Infraprojects has secured a major highway project worth Rs 4,262.78 crore from NHAI. The project involves the construction and upgrading of the Agra-Gwalior road, spanning Uttar Pradesh, Rajasthan, and Madhya Pradesh.
Brigade Enterprises
Brigade Enterprises and Gruhas have launched ‘Earth Fund’, a Rs 200 crore investment platform focusing on proptech and sustainability-driven startups. The SEBI-registered fund will support startups solving critical challenges in real estate, construction, and green technology.
Zydus Lifesciences
Zydus Lifesciences has received final approval from the USFDA to manufacture and market apalutamide tablets, a generic version of Erleada. The drug is used to treat metastatic castration-sensitive prostate cancer and will be produced at Zydus’ Ahmedabad facility.
Hindustan Zinc
Hindustan Zinc is facing a challenging period. The Vedanta Group subsidiary has been fined Rs 5.42 lakh by both BSE and NSE for failing to meet the board composition norms. The penalty is due to a shortfall in the required number of Independent Directors as per SEBI’s listing regulations.
These are the key updates for today, which may influence the market.
